126 related articles for article (PubMed ID: 1827020)
21. MIDAS, the Multicenter Isradipine/Diuretic Atherosclerosis Study. Design features and baseline data.
Applegate WB; Byington RP
Am J Hypertens; 1991 Feb; 4(2 Pt 2):114S-117S. PubMed ID: 1827000
[TBL] [Abstract][Full Text] [Related]
22. Blood pressure control and haemodynamic adaptation with the dihydropyridine calcium antagonist isradipine: a controlled study in middle-aged hypertensive men.
Andersson OK; Persson B; Hedner T; Aurell M; Wysocki M
J Hypertens; 1989 Jun; 7(6):465-9. PubMed ID: 2528578
[TBL] [Abstract][Full Text] [Related]
23. Isradipine in Asian patients with hypertension.
Zubair M; Karim S; Hussain S
Drugs; 1990; 40 Suppl 2():26-9. PubMed ID: 2150636
[TBL] [Abstract][Full Text] [Related]
24. Acute antihypertensive and renal effects of isradipine in hypertensive patients with normal and reduced renal function.
Wittenberg C; Rosenfeld JB
Am J Hypertens; 1991 Feb; 4(2 Pt 2):191S-193S. PubMed ID: 1827019
[TBL] [Abstract][Full Text] [Related]
25. Time course of the blood pressure response to oral isradipine in uncomplicated mild-to-moderate essential hypertension.
Leary WP; Reyes AJ; Maharaj B; van der Byl K
Am J Hypertens; 1991 Feb; 4(2 Pt 2):147S-150S. PubMed ID: 1827006
[TBL] [Abstract][Full Text] [Related]
26. The calcium antagonist isradipine in the therapy of hypertension. A double-blind crossover comparison with nifedipine.
Welzel D; Burger KJ
Drugs; 1990; 40 Suppl 2():60-4. PubMed ID: 2150644
[TBL] [Abstract][Full Text] [Related]
27. Effect of isradipine on factors affecting blood viscosity.
Slonim A; Paran E; Cristal N
Am J Hypertens; 1991 Feb; 4(2 Pt 2):172S-174S. PubMed ID: 1827013
[TBL] [Abstract][Full Text] [Related]
28. Isradipine: overall clinical experience in hypertension in the United States.
Miller H
Am J Hypertens; 1991 Feb; 4(2 Pt 2):135S-139S. PubMed ID: 1827004
[TBL] [Abstract][Full Text] [Related]
29. Slow-release isradipine in mild to moderate hypertension: hemodynamic and antihypertensive effects.
Celentano A; Galderisi M; Tammaro P; Mureddu GF; Garofalo M; de Simone G; de Divitiis O
Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):494-8. PubMed ID: 1839903
[TBL] [Abstract][Full Text] [Related]
30. Hemodynamic study of short- and long-term isradipine treatment in patients with chronic ischemic congestive heart failure.
McGrath BP; Newman R; Older P
Am J Med; 1989 Apr; 86(4A):75-80. PubMed ID: 2523660
[TBL] [Abstract][Full Text] [Related]
31. Low-dose isradipine once daily effectively controls 24-h blood pressure in essential hypertension.
Diemont WL; Stegeman CJ; Beekman J; Siegers AM; Hagels G; de Bruijn JH
Am J Hypertens; 1991 Feb; 4(2 Pt 2):163S-167S. PubMed ID: 1827011
[TBL] [Abstract][Full Text] [Related]
32. Management of perioperative hypertension using intravenous isradipine.
Rüegg PC; Karmann U; Keller H
Am J Hypertens; 1991 Feb; 4(2 Pt 2):203S-206S. PubMed ID: 1827023
[TBL] [Abstract][Full Text] [Related]
33. Effects of isradipine on platelet function in hypertension at rest and during exercise.
Fitscha P; Virgolini I; Rauscha F; Sinzinger H
Am J Hypertens; 1991 Feb; 4(2 Pt 2):178S-180S. PubMed ID: 1827015
[TBL] [Abstract][Full Text] [Related]
34. Postexercise reflex control of forearm vascular resistance during calcium antagonism with slow-release oral isradipine.
Cléroux J; Kouamé N; Yardley C; Marshall A; Lacourcière Y
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S66-9. PubMed ID: 1376840
[TBL] [Abstract][Full Text] [Related]
35. Isotonic and isometric responses of blood pressure and heart rate in mild to moderate hypertension with isradipine and propranolol.
Cantor A; Cristal N
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S76-8. PubMed ID: 1695309
[TBL] [Abstract][Full Text] [Related]
36. Isradipine in the treatment of hypertension. Some additional effects observed during a one-year study.
Mayer O; Polivkova H; Rottenborn J
Am J Hypertens; 1991 Feb; 4(2 Pt 2):140S-143S. PubMed ID: 1827005
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular effects of isradipine (Lomir) with special emphasis on haemodynamics and antihypertensive efficacy. A review.
Dahlöf B
Cor Vasa; 1990; 32(2 Suppl 1):23-34. PubMed ID: 2143458
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension.
Winer N; Thys-Jacobs S; Kumar R; Davidson WD; Grayson M; Harris C; Walker D; Itskovitz H; Gonasun L
Clin Pharmacol Ther; 1987 Oct; 42(4):442-8. PubMed ID: 2959426
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic response, safety, and efficacy of isradipine in the treatment of essential hypertension.
Dahlöf B
Am J Med; 1989 Apr; 86(4A):19-26. PubMed ID: 2523651
[TBL] [Abstract][Full Text] [Related]
40. Multicenter evaluation of efficacy, tolerability and safety of a new first-line antihypertensive drug, isradipine, in a Latin-American population.
Gómez G; Melgarejo E; Narváez J; Gamarra G; Restrepo G; Acevedo L; Izurieta A
Am J Hypertens; 1991 Feb; 4(2 Pt 2):128S-130S. PubMed ID: 1827002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
